Expression of proadrenomedullin-derived peptides in the rat, cow and human pituitary was studied by a variety of techniques. Immunocytochemical detection showed a widespread expression of adrenomedullin peptide in the adenohypophysis and the neural lobe, with low expression in the intermediate pituitary. Proadrenomedullin N-20 terminal peptide (PAMP)-immunoreactivity was also present in the anterior pituitary but showed a more marked heterogeneous distribution, with cells going from very strong to negative immunostaining. Lower levels of PAMP were found in the neural lobe. Interestingly, the distribution of adrenomedullin and PAMP immunoreactivity in the anterior pituitary did not completely overlap. In the present study, we concentrated our efforts to determine which cell type of the adenohypophysis expresses PAMP. Paraffin and semithin serial sections immunostained for PAMP and the classical pituitary hormones revealed that a subpopulation of the gonadotropes expresses high levels of PAMP-immunoreactive material. Ultrastructural analysis clearly showed PAMP-immunoreactivity in the follicle stimulating hormone (FSH)-containing large secretory granules of the gonadotropes, suggesting simultaneous secretion of PAMP and FSH by this cell type. Three mouse adenohypophysis-derived cell lines (AtT20, GH3, and aT3-1 derived from corticotropes, lacto/somatotropes and gonadotropes, respectively) were also analysed and showed expression of both proadrenomedullin-derived peptides and their mRNA. Functional studies in these three cell lines showed that neither adrenomedullin nor PAMP was able to stimulate cAMP production in our experimental conditions. Taken together, our results support that proadrenomedullin derived peptides are expressed in the pituitary in cell-specific and not overlapping patterns, that could be explained by differences in postranslational processing. Our data showing costorage of PAMP and FSH in the same secretory granules open a way by which PAMP could be involved in the control of reproductive physiology in a coordinated manner with FSH.
concentrations than its gene-related peptide adrenomedullin adrenomedullin concentrations measured by radioimmunoassay (RIA) are higher in the pituitary than in any (8, 9) .
Although most of the investigative groups working on AM other organ, except for the adrenals. This suggested differential regulation of the expression of PAMP in the pituitary are concentrated on this peptide's role in cardiovascular function, it has now been realized that adrenomedullin may compared to other tissues. In the present study, we show that there is differential regulation in the expression of both have much broader pluripotent properties, such as the modulation of bronchodilation (10), aldosterone (11) or insulin peptides in separate cell types within the mammalian hypophysis. (12) secretion, or glomerular filtration and fractional sodium reabsorption (13) . More recently, the involvement of AM in the regulation of growth and proliferation has also been Materials and methods reported for several cell types in which it has either a stimulatory (fibroblastic or tumoral cells) or inhibitory Tissues (mesangial cells) effect (14) . Broad agreement has now been Male and female adult Fisher rats were used to obtain the pituitary. Rats were killed by inhalation of CO 2 and rapidly decapitated. Pituitaries and achieved towards the concept that adrenomedullin is a multiadrenal glands were also obtained from normal cows and pigs used for other functional peptide, similar in activity to tumour growth investigations approved by several USDA experimental protocols. These factor-b. 1-52 in reverse phase high-performance liquid chromatography (18 adrenomedullin. This lack of information prompted us to PAMP immunoreactivity in pituitary tissues and cell lines (24, 25) . The investigate the distribution of adrenomedullin and PAMP antibody against adrenomedullin was directed to AM 22-52 amide (Cexpression in the mammalian pituitary. We were also particuterminal ). The antibody against PAMP was directed to PAMPYY 13-20 amide (C-terminal ). Antibodies against rat prolactin (rPRL-IC-5), rat growth larly intrigued by the fact that the ratios of reported PAMP/ hormone (rGH-IC-1), rat thyroid stimulating hormone ( THS-IC-1), rat FSH staining was observed in the endocrine cells that were more strongly stained with the antisense probe, probably due to incomplete linearization of the (rFSH-IC-1), rat LH (rLH-IC-1), and human ACTH (hACTH-IC-2) were generously donated by the National Hormone and Pituitary Program of plasmid combined with leakage of the unused promotor. NIDDK, NIH, USA.
Western blot Immunocytochemical technique
To extract the proteins, the cell samples were immersed in cold 2X tricine For the immunocytochemical localization of adrenomedullin and PAMP in sample buffer (with 8% SDS, NOVEX, San Diego, CA, USA) containing paraffin sections, the avidin-biotin complex (ABC ) technique was employed.
1 mM final concentration of each of the following protease inhibitors: Optimal dilution for anti-AM 22-52 was 151000, whereas the anti-PAMP pefabloc (Centerchem Inc., Stamford, CT, USA), bestatin and phosphorami-10-20 was used at 15700. Following overnight treatment with the primary don (Sigma). The cells were then homogenized, sonicated, clarified by antiserum, sections were incubated with biotinylated goat antirabbit antiserum ultracentrifugation, and the final protein concentration determined (BCA kit, ( Vector Laboratories, Burlingame, CA, USA) diluted 15200. The sections Pierce, Rockford, IL, USA). Protein extracts were diluted to an approximate were then treated with the avidin-biotin peroxidase complex ( Vector protein concentration of 35 mg/50 ml, heated to 95°C for 3 min and loaded Laboratories) diluted 15100 in PBS. Peroxidase activity was demonstrated into the sample well. Cell or tissue protein extracts were electrophoretically using diaminobenzidine/H 2 O 2 as chromogen and substrate, respectively. separated on a gradient 10-20% tricine, SDS-PAGE gel (NOVEX ), and run Finally, the sections were lightly counterstained with Gills' haematoxylin. In at 100 V for 2 h under reducing 0,5% b-mercaptoethanol conditions. One ng some cases, the reaction was intensified with metallic nickel (26) . The of synthetic adrenomedullin or 5 ng of PAMP was added to a separate well intensifying developing reagent was made by mixing a solution of 50 mg of as a positive control. Transfer blotting was accomplished in the same DAB in 50 ml of deionized H 2 O with a second solution made up by adding apparatus equipped with a titanium plate electrode and transferred to a 2.5 g of ammonium nickel sulphate (di-Ammonium nickel ( II ) sulphate polyvinyldifluoride membrane ( Immobilon PVDF, Millipore, Bedford, MA, 6-hydrate; BDH Laboratory Supplies, UK ), 200 mg of b--glucose (Sigma USA) at 30 V for 3 h. The membrane was blocked overnight in 1% BSAChemical Co., St Louis, MO, USA), 40 mg of ammonium chloride (Sigma) PBS, incubated for 1 h in 151000 dilution of rabbit anti-AM 22-52 (#2469) and 30 mg of glucose oxidase (Sigma), in 50 ml of acetate buffer (acetic acid or anti-PAMP 10-20 (# 2463), washed three times in PBS, exposed to 0.1 M pH 6).
1×106 cpm 125I-Protein A for 30 min at 4°C, washed 6 times in PBS, dried Solid-phase absorption controls were carried out by preincubation (overand autoradiographed overnight at −80°C on Kodak XAR5 film. Specificity night at 4°C ) of the primary antiserum with the equivalent peptide previously control consisted of a duplicate membrane incubated in antigen-preabsorbed adsorbed to the wall of a polystyrene tube at a concentration of 10 mg/ml.
(10 nmol/ml ) antiserum. Another negative control included the use of nonimmune swine serum as first
Northern blot layer and gave no immunocytochemical reaction.
Immunocytochemistry at the semithin level was carried out as follows. Equal amounts of total RNA (20 mg) were electrophoresed on 1% agarose After removing the plastic with a saturated solution of NaOH in methanol gels containing 0.66 M formaldehyde, transferred to 'Nytran' filters (Scleicher (27) , semithin sections were rinsed in absolute ethanol, rehydrated in a graded and Schuell, Keene, NH, USA), UV cross-linked and baked for 3 h. Ethidium series of ethanol, and washed twice in TRIS-HCl buffered saline. The avidinbromide (33 mg/ml ) was included in the gel to visualize the position of biotin peroxidase complexes method was identical to that described above, ribosomal RNAs by ultraviolet illumination after electrophoresis. but microwave pretreatment was used and the incubation time for the primary Hybridization was performed using a 0.55-kb EcoRI fragment of mouse antisera was increased to 48 h. Microwave pretreatment consisted in a first adrenomedullin (plasmid pcRIIAM ). Blots were hybridized with 32P-labelled 15 min incubation of the sections in a citrate buffer 0.01 M, pH 6.0 at full (3000 Ci/mmol, DuPont, Boston, MA, USA) random-primed probes at 65°C, microwave heating power, followed by a second 15 min incubation in the washed and exposed at −70°C using a DuPont Lightning Plus intensifying same buffer at half power and a 5-min incubation without heating. Finally, screen (DuPont). the sections were washed during 10 min in running water. The reaction was cAMP assay intensified with nickel as described above.
Cyclic AMP was assayed by RIA. Cells in 24-well plates were resuspended Ultrastructural immunolabelling in SIT medium (3×10−8 M Se 2 O 3 ; insulin, 5 mg/ml; transferrin, 10 mg/ml ) For the ultrastructural studies, the colloidal-gold technique of Merighi et al.
containing 1% BSA, 1 mg/ml bacitracin, and 100 mM isobutyl-methyl-(28) was applied to thin sections mounted on nickel grids. Non-specific xanthine. Adrenomedullin or PAMP was added and after 5 min the reaction binding sites were blocked with 10% goat immunoglobulins in a buffer [Gold terminated by adding equal volumes of ethanol (0.5 ml ). The cAMP RIA kit Buffer, GB, Tris-Buffered Saline with 1% bovine serum albumin (BSA) and was purchased from NEN (Boston, MA, USA). 0.05% sodium azide] that was also used for the remaining steps. Thin sections were incubated overnight at 4°C with the primary rabbit antiserum (15200) in GB. Subsequent steps, all at room temperature, included rinses in GB,
Results
incubation with the gold-labelled secondary antiserum (goat antirabbit immunoglobulins conjugated to 20-nm gold particles, Biocell Research
Immunocytochemistry of mammalian pituitary
Laboratories, Cardiff, UK ) for 1 h, rinses in GB and distilled water, and double staining with uranyl acetate and lead citrate. The grids were observed Immunoreactivity for adrenomedullin and PAMP was found with a transmission electron microscope.
in human, rat, and cow anterior pituitary ( in the intermediate lobe (Fig. 1B,C ) . The posterior lobe although in these species the heterogeneity in the intensity of adrenomedullin was higher as compared to the rat. Western showed a homogeneous weak immunoreaction for PAMP, that was readily absorbed in the controls (Fig. 1B-D) . In the blot of human pituitary extracts (Fig. 2 ) gave adrenomedullin and PAMP immunoreactive bands, mainly corresponding to anterior lobe, three types of cells could be distinguished according to the immunostaining pattern for PAMP: some the proadrenomedullin molecule (approximately 22 kDa) and a processed species (aproximately 17 kDa). In 2 out of 10 cells were strongly positive, a second subpopulation showed a positive immunoreaction of lower intensity and a third cases of human pituitary studied (shown in Fig. 2 ), a 6-kDa species, very likely corresponding to completely processed subpopulation of cells were completely negative for this antibody (Fig. 1B,C,E-H ) . In the rat, the cells expressing adrenomedullin could be detected in the western blot using anti-adrenomedullin antibodies. Similar bands could be high levels of PAMP-immunoreactive material tended to be concentrated in the periphery of the anterior lobe, but detected in western blots of cow pituitary (data not shown). especially near the intermediate pituitary at the tuberal portion (Fig. 1C ) . Image analysis with relative measurements Expression of adrenomedullin mRNA in the rat pituitary (area percentage of immunostained cells vs stained plus non stained cells) showed significant differences (P<0.002)
In situ hybridization experiments revealed the presence of the mRNA for adrenomedullin in a variety of endocrine cells of between sexes in the immunocytochemical detection of PAMP in rat pituitary, the males showing higher immunostained the rat anterior pituitary (Fig. 1I-K ) . Not all the cells of the adenohypophysis showed detectable levels of adrenomedullin area percentage than the females. A similar pattern of distribution of adrenomedullin and PAMP immunostaining was mRNA by this technique, and some degree of heterogeneity of the intensity of staining suggested differences in the levels observed when human and cow pituitary were stained, of expression among the positive cell types. Intermediate and neural hypophysis were negative for adrenomedullin mRNA expression. Sense probes were used as controls and rendered negative results. The in vitro transcription product from an empty plasmid was also used as a negative control and gave completely negative staining.
Expression of adrenomedullin in mouse pituitary cell lines
In order to compare the expression of adrenomedullin and PAMP in different pituitary cell types, mouse cell lines aT3-1, AtT-20 and GH3 (derived from mouse gonadotrope-, corticotrope-and somatotrope/lactotrope-adenomas), were used. Western blot (Fig. 3A) , northern blot ( Fig. 3B) and immunocytochemical (Fig. 4) analysis were carried out. Western blot analysis for adrenomedullin usually did not show immunoreactive bands for a 6-kDa species corresponding to bioactive adrenomedullin, but clearly produced other two more intense bands of higher molecular weight (17 and 22 kDa, respectively) in the three cell lines examined. The 22 kDa band was stronger in the aT3-1 extracts than in those of the other two cell lines. When antibodies against PAMP were used in this type of analysis, no band for processed PAMP was observed in any of the three cell lines, although in all of them the two bands for the precursor (17 and 22 kDa) were readily detected by this antibody (Fig. 3A) . Northern blot analysis in these cell lines revealed an important Strong signal by adrenomedullin-like and PAMP-like immunoreactive material was observed in the three cell lines. No obvious difference in the immunohistochemical intensity among the three was found (Fig. 4A-F ) .
was useful to discard GH-, PRL-, and ACTH-producing cells as the main PAMP-immunoreactive cell type via the comparison of staining patterns. However, the thickness of the sections precluded cell-to-cell accurate comparison that could Serial sections and ultrastructural studies show colocalization of both PAMP and any of the classical hormones in the same cell. In order to solve this problem, In order to further characterize this heterogeneous population of cells, and especially to ascertain which cell type corresponds two technical approaches were carried out: serial semithin sections of plastic embedded material and ultrastructural to the PAMP strongly immunoreactive cells, we conducted immunostaining experiments in serial consecutive paraffin studies. In order to find out which of the classical pituitary cell sections with antibodies directed against PAMP and the classical pituitary hormones (data not shown). This approach types is expressing higher levels of PAMP in the pituitary, we studied semithin and thin sections. Although some degree tural level showed that the PAMP-immunoreactive material was restricted to the larger FSH-containing granules of the of antigenicity loss is usually caused by the plastic embedding procedures, we trusted that the high levels of staining gonadotropes (Fig. 6) . Unfortunately, our antibodies against adrenomedullin did not work on semithin plastic-embedded observed at the paraffin level would permit visualization of the PAMP immunoreactive material in semithin sections and sections or at the ultrastructural level with the colloidal-gold technique in pituitary. Therefore, conclusions about the electron microscopy, at least in the subpopulation of strongly immunoreactive cells. Using this approach, we were able to expression and distribution of adrenomedullin have to be drawn only from the data obtained with the paraffin embedshow a clear colocalization of PAMP with FSH-LH containing gonadotropes (Fig. 5) . In semithin sections, both very ded tissues and cell lines. intense and intermediate PAMP immunoreactive cells were observed and serial sections showed also that they were not
Effect of adrenomedullin and PAMP on cAMP in pituitary cell immunoreactive for PRL, GH, ACTH or TSH (Fig. 5A-F ) lines but colocalized with FSH and, in some cells, with LH ( Fig. 5G-J ) . All the PAMP-immunoreactive cells are also Adrenomedullin and PAMP are secreted peptides which may have either local (autocrine-paracrine) or distant (endocrine) immunostained for FSH and LH. LH cells not immunoreactive for FSH and PAMP were also found with this approach actions. In order to get an idea of the possible target of the secreted peptide, we have performed experiments of cAMP (Fig. 5G,H ) , together with LH and FSH immunoreactive cells that are negative for PAMP (Fig. 5G-J, double arrow) . stimulation of the mouse pituitary cell lines with adrenomedullin or PAMP. Both adrenomedullin and PAMP failed to Crossed absorption controls were carried out by incubation of the anti-PAMP antibodies with either LH or FSH stimulate cyclic AMP production in the three cells lines that were readily stimulated by either PACAP (Fig. 7) or forskolin (20 nmol/ml ) before the immunostaining procedure. Neither of the two hormones blocked or reduced the immunostaining (data not shown). levels for PAMP. A further confirmation of our results came form the analysis of the localization of PAMP immunoDiscussion staining at the ultrastructural level (Fig. 6 ). Colloidal gold immunocytochemistry was carried out in order to confirm
In the present paper, we have shown the expression of adrenomedullin and its related peptide PAMP in the mammathe gonadotropic-specific ultrastructural features of the PAMP-immunoreactive cells. This EM approach was used to lian pituitary. We have also demonstrated a very noticeable expression of PAMP-immunoreactive material in the gonaascertain which of the two subpopulation of granules present in gonadotropes, known to contain either LH or FSH, dotropes which is consistent with previously reported radioimmunoassay data on PAMP in the pituitary (9). Prior expressed the stored PAMP-like material. Our results clearly demonstrated that the only subpopulation of cells in the studies on mammalian tissue extracts have identified a significantly higher PAMP/adrenomedullin ratio in the pituitary anterior pituitary which expressed PAMP immunoreactivity at the semithin and ultrastructural level were the gonaas compared to other organs in which both peptides have been found (9). Our report is the first to show PAMP dotropes. Moreover, immunolocalization at the ultrastruc- immunoreactivity in pituitary and its localization in FSH/LH conflict with prior observations by Washimine et al. (19) . In their 1995 report, an overview of immunocytochemical anacells and the first to demonstrate by western blot that adrenomedullin precursor is expresed and processed in human lysis of adrenomedullin in a variety of human, rat and pig organs, including anterior and posterior pituitary, under their pituitary. All of our western analysis show two bands at 22 kDa and 17 kDa. The 22 kDa product may correspond to experimental conditions, no immunoreactivity was found for adrenomedullin in the posterior pituitary of any of the three the preproadrenomedullin peptide (185 amino acids) and the 17 kDa band could correspond to an intermediate product species studied, nor in the anterior pituitary of the rat. In the anterior lobe of human and porcine pituitary, the authors of a first cleavage but still a precursor molecule that may contain the amino acid sequences of both adrenomedullin found adrenomedullin immunoreactive cells with a distribution different from GH, PRL and ACTH cells. Our results and PAMP peptides, as is shown by the immunoreaction with both antibodies. In any case, none of these precursor do not exclude that cells belonging to these cell types express adrenomedullin. Although so far we have not been able to peptides have been isolated and sequenced yet. We intend to do so in the near future.
achieve good immunoreactivity for semithin plastic embedded sections with our anti-adrenomedullin antibody, we aim to Our immunocytochemical results using antiadrenomedullin antibodies are in line with our previous try new strategies to find out the correlation between adrenomedullin-immunoreactivity and the classical pituitary reports on foetal rat and mouse embryogenesis (24) and with a recent report on general distribution of adrenomedullin in hormones. The differences found between our immunocytochemical results and those of Washimine et al., namely their rodents using in situ hybridization techniques (29) . Among many other organs, these reports show expression of adrenolack of immunoreaction in rat pituitary compared to the abundant expression shown in our data, may be due to the medullin both in the anterior and posterior lobes of the pituitary. On the contrary, the present data is in partial different characteristics of the antibodies used. In fact, these authors also report negative staining in organs such as brain, phoretically separable adrenomedullin-and PAMP-immunoreactive species in cow pituitary and adrenals, also suggesting kidney or heart, which have now been shown, by other laboratories using different antibodies, to contain immunoreorgan-specific postranslational regulation. An adenohypophysis-specific processing of preprocholecystokinin, with most active adrenomedullin (13, 30, 31) .
The lack of complete overlapping of adrenomedullin and of the propeptide processed to immature non amidated large peptides, instead of the small amidated products that predom-PAMP immunoreactivity that we have found, may be due to cell-specific processing of the preproadrenomedullin molecule inate in the principal production sites of gastrin and cholecystokinin-8, has also been reported (33) . Although cellin each pituitary cell type, in particular the gonadotropes. All the data available to date on the expression of PAMP in specific post-translational regulation of peptides is a wellestablished phenomenon, for example in the proopiomelanomammals show that the concentration of this peptide in the plasma or in tissues is always lower than that of adrenomedulcortin derived peptides (e.g. 34), very little data are available about this fact in relation to the proadrenomedullin derived lin. For example, the average human plasma adrenomedullin concentration in normal adults is around 5.5±0.21 fmol/ml peptides. One of the enzymes required for postranslational modification of adrenomedullin precursor, peptidyl-glycine (15), whereas PAMP is 0.78±0.12 fmol/ml (8) . Consistent with these data, in our hands immunocytochemical staining a-amidating monooxygenase (PAM ), is also widely expressed in the anterior pituitary and preferentially produced by the using antibodies against PAMP in other organs always render much fainter signal compared to the results using antibodies gonadotropes (35) . The gonadotropes are particularly rich in a PAMP-immuagainst adrenomedullin (e.g. 24). The pituitary gonadotropes are a very striking exception to this rule, with a more intense noreactive species and there is a significantly higher expression of this molecule in the subtype of gonadotropes that accumusignal for PAMP than for adrenomedullin, suggesting that an important difference exist in the processing of the adrenolate FSH, than in those that are mainly LH secretors. Heterogeneity within a given cell type in the pituitary cell medullin precursor protein in this cell type. Cell type-specific differences in the processing of preproadrenomedullin have population is a well established phenomenon that occurs mainly in the somatotrope/lactotrope and in the gonadotrope also been suggested to explain the significant decrease of the PAMP/adrenomedullin ratio in protein extracts of pheocromcell populations (36) . The possible cosecretion of this PAMPimmunoreactive material and LH/FSH was further supported ocytoma (20%) when compared to normal human adrenals (39%) (32) . Our own unpublished results also show a marked when we performed immunocytochemical techniques at the ultrastructural level, showing the very precise localization of variability in the relative abundance of the different electro-for adrenomedullin is more widespread than that of PAMP, although not so intense. Consistent with this widespread expression of adrenomedullin in the several cell types that comprise the pituitary, adrenomedullin mRNA and both adrenomedullin and PAMP protein were shown to be abundant in the three cell lines studied GH3, AtT20 and aT3-1 that are derived, respectively, from mouse somatotropes/lactotropes, corticotropes and gonadotropes.
A detailed analysis of the promoter region of the human and mouse adrenomedullin genes (Genbank accession nos. D43639 and D78349, respectively) suggests that a number of putative binding sites for well established pituitary-specific transcription factors are present, giving further support to our finding of high expression of this gene in pituitary tissues and cell lines. Both in human and mouse adrenomedullin gene promoter, at least one potential gonadotropic-specific element (GSE), a binding site for steroidogenic factor-1 (SF-1), was found at −779, −754 (reverse) in human and −729 in mouse (Fig. 8) . SF-1 is a member of the steroid receptor superfamily that has been shown necessary for gonadotrope differentiation within the pituitary. SF-1 is a transcriptional activator of the human a-subunit, the gonadotropin-releasing hormone receptor and the LH-b genes the PAMP-immunoreactive material to the gonadotrope secretory granules, especially those of larger size. Furthermore, the sex-specific differences in the expression of PAMP are parallel to what has already been described for FSH-containing cells in rat pituitary. A thorough light microscopy and ultrastructural characterization of the heterogeneous rat gonadotrope population has recently been published (37) showing two main types of morphologically and immunoreactivelly distinct granules: a small round electrondense granule with an average diameter of 200 nm and a larger less opaque granule of 400-700 nm, the former type being only immunoreactive to LH antibodies and the later accumulating both LH and FSH. PAMP immunoreactivity was mainly localized to the larger FSH containing granules, suggesting a possible simultaneous release of PAMP and FSH upon stimulation, and also supporting a possible involvement of PAMP or adrenomedullin in the regulation of reproductive functions. Changes in the expression of adrenomedullin in the female reproductive organs, in parallel with the reproductive cycle have already been reported (38) . The high concentration of cell types making adrenomedullin. In fact, immunostaining (39-41) in the gonadotropes and is highly expressed in this and maybe an involvement of adrenomedullin-related peptides in the hormonal control of reproductive functions. cell type (42) but not in the other pituitary endocrine cells. These findings and the localization of a proadrenomedullinIn summary, our collective data demonstrate the expression of proadrenomedullin derived peptides in the endocrine cells derived peptide found in our study in the gonadotropes suggest that SF-1 may be implicated in the regulation of of the pituitary in a variety of mammalian species. In addition, these peptides have been found in adenohypophysis-derived adrenomedullin-gene expression through the GSE present in its promoter. Putative consensus sequences for other adenohycell lines. We have also localized PAMP-like immunoreactive material to the FSH-containing granules of the gonadotropes. pophysis-specific transcription factors have also been found in the 5∞ adrenomedullin promoter region of both human and Our morphological and functional data suggest a possible involvement of the proadrenomedullin derived peptides in mouse genes [for a review on pituitary transcription factors, see (43) ]. Pit-1, a helix-turn-helix homeobox protein has been the central endocrine control of reproduction. the object of numerous studies and has been shown to regulate the expression of the GH, PRL, TSHa and growth
